Table 3.

FEV₁ and FVC in participants with DM stratified by ACR compared with those without DM

	Without lung disease (n = 11,152)				With lung disease (n = 2,510)
	Non-DM with ACR <30 mg/g (n = 8,852)	DM with ACR <30 mg/g (n = 1,752)	DM with 30 ≤ ACR ≤ 300 mg/g (n = 442)	DM with ACR >300 mg/g (n = 106)	Non-DM with ACR <30 mg/g (n = 1,851)	DM with ACR <30 mg/g (n = 509)	DM with 30 ≤ ACR ≤ 300 mg/g (n = 126)	DM with ACR >300 mg/g (n = 24)
FEV1 (L)	3.11 (3.10–3.13)	3.01 (2.97–3.06)	3.01 (2.95–3.07)	2.91 (2.83–2.99)	2.99 (2.96–3.02)	2.86 (2.79–2.93)	2.83 (2.72–2.93)	2.58 (2.31–2.84)
P value	Reference	<0.001	<0.001	<0.001	Reference	<0.001	0.005	0.003
FVC (L)	3.83 (3.81–3.84)	3.65 (3.60–3.70)	3.61 (3.54–3.68)	3.46 (3.33–3.59)	3.77 (3.74–3.80)	3.57 (3.49–3.65)	3.50 (3.37–3.63)	3.22 (2.89–3.56)
P value	Reference	<0.001	<0.001	<0.001	Reference	<0.001	<0.001	0.002
Dyspnea score	0.41 (0.34–0.49)	0.54 (0.42–0.67)	0.73 (0.53–0.94)	1.01 (0.45–1.57)	0.71 (0.47–0.94)	1.19 (0.86–1.51)	1.21 (0.71–1.71)	1.83 (1.00–2.67)
P value	Reference	0.02	0.002	0.04	Reference	0.0002	0.04	0.008

Data are mean (95% CI) unless otherwise indicated. Adjusted for age, sex, height, WC, Latino background, cumulative smoking, and history of HF (for FEV₁ and FVC) and CAD (for dyspnea score).